1.
Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort
by Jiang, Rong, PhD
The American heart journal, 2017, Vol.190, p.40-45

2.
Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies
by Allen, Norrina B., PhD
The American heart journal, 2016, Vol.175, p.112-120

3.
The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women
by Ahmad, Tariq, MD
The American heart journal, 2010, Vol.160 (6), p.1163-1169

4.
The genetic response to short-term interventions affecting cardiovascular function: Rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study
by Mitchell, Braxton D., PhD
The American heart journal, 2008, Vol.155 (5), p.823-828

5.
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Dis...
by Shah, Svati H., MD, MS, MHS
The American heart journal, 2010, Vol.160 (3), p.371-379.e2

6.
Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)
by Eagle, Kim A., MD
The American heart journal, 2009, Vol.157 (2), p.319-326

7.
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): Results from phase I and scientific opportunities in phase II
by Kroner, Barbara L., PhD
The American heart journal, 2011, Vol.162 (4), p.627-632.e1

8.
Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and in...
by Albert, Michelle A., MD, MPH
The American heart journal, 2009, Vol.157 (4), p.777-783.e1

9.
Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study
by Ilercil, Arzu
The American heart journal, 2001-06, Vol.141 (6), p.992-998

10.
Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study
by Keaney, John F., MD
The American heart journal, 2008, Vol.156 (5), p.1003-1009.e1

11.
Light-dark patterns of soluble CD40 ligand: Clinical implications
by Dominguez-Rodríguez, Alberto, MD, PhD
The American heart journal, 2009, Vol.157 (2), p.e3-e3

12.
Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease
by Winkelmann, Bernhard R
The American heart journal, 1999, Vol.137 (4), p.698-705

13.
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: The ATTICA study
by Chrysohoou, Christine
The American heart journal, 2004, Vol.148 (4), p.733-738

14.
Protective effect of the CYP2C19 17 polymorphism with increased activation of clopidogrel on cardiovascular events
by Tiroch, Klaus A., MD, PhD
The American heart journal, 2010, Vol.160 (3), p.506-512

15.
Discrimination: A new cardiovascular risk factor?
by Thomas, Kevin L., MD
The American heart journal, 2008, Vol.156 (6), p.1023-1025

16.
Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia
by Mozas, P
The American heart journal, 2003, Vol.145 (6), p.999-1005

17.
Creation of a large-scale genetic data bank for cardiovascular association studies
by Agah, Ramtin
The American heart journal, 2005, Vol.150 (3), p.500-506

18.
Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease
by Ogimoto, Akiyoshi
The American heart journal, 2005, Vol.150 (1), p.e1-e1

19.
Genetic analysis for common complex disease
by Hauser, Elizabeth R
The American heart journal, 2000-10, Vol.140 (4), p.S36-S44

20.
Genetic susceptibility to cardiovascular diseases
by Roses, Allen D
The American heart journal, 2000-10, Vol.140 (4), p.S45-S47
